Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-07-31
2000-02-08
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514282, 514341, 514362, 514363, 514370, 514380, 514387, 514389, 514646, A01N 4358
Patent
active
06022875&
ABSTRACT:
Disclosed in this invention is a method of analgesic treatment comprising administering an effective analgesic amount of a substituted 2,4-imidazolidinedione compound.
REFERENCES:
patent: 5733936 (1998-03-01), Buschmann et al.
patent: 5811582 (1998-09-01), Buschmann et al.
Randall et al., Arch. int. pharmacodyn. CXI, No. 4, pp. 409-19 (1957).
Litchfield et al., J. Pharmacol, Exp Ther. 113: 96-99 (1949).
Dubuisson et al., Pain, 4: 161-74 (1977).
Hunskaar et al., Pain, 30: 103-14 (1987).
Witkin et al., J. Pharmacol. Exp. Ther. 133: 400-08 (1961).
Patent Abstracts of Japan, abstract of JP 55-051,068, 1980.
Patent abstracts of Japan, abstract of JP 09-176,131, 1997.
Satsangi et al., "1-(4-substituted-thiazol-2-yl) Hydantoins as Anti-Inflammatory and CNS-Active Agents". Pharmazie 38:341-2 (1983).
Selve Norma
Zimmer Oswald
Gruenenthal GmbH
Jarvis William R. A.
LandOfFree
Use of substituted 2,4-imidazolidinedione compounds as analgesic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of substituted 2,4-imidazolidinedione compounds as analgesic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of substituted 2,4-imidazolidinedione compounds as analgesic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1681648